Filing Details

Accession Number:
0001209191-21-012544
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-19 19:08:10
Reporting Period:
2021-02-18
Accepted Time:
2021-02-19 19:08:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1016169 Antares Pharma Inc. ATRS Surgical & Medical Instruments & Apparatus (3841) 411350192
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1049713 S Leonard Jacob C/O Antares Pharma, Inc.
100 Princeton South, Suite 300
Ewing NJ 08628
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-18 15,321 $2.24 268,363 No 4 M Direct
Common Stock Disposition 2021-02-18 15,321 $5.05 253,042 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-02-18 15,321 $0.00 15,321 $2.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-09-08 No 4 M Direct
Footnotes
  1. The stock option exercise and sale of common stock reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The options vested and become exercisable one year from the grant date of September 9, 2011.